Anoikis triggers Mdm2-dependent p53 degradation

Molecular and Cellular Biochemistry

Volumn 343, Issue 1-2, 2010, Pages 201-209

  Ghosh, Abhijit ^a   Chen, Tina Chunyuan ^a   Kapila, Yvonne L ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

Extracellular matrix; Fibronectin; Mdm2; p53; Periodontitis; Proteasome

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; FIBRONECTIN; MUTANT PROTEIN; PROTEASOME; PROTEIN MDM2; PROTEIN P53; RECOMBINANT PROTEIN; SMALL INTERFERING RNA;

ANOIKIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION;

ANOIKIS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYDROLYSIS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77957572800     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0514-6     Document Type: Article

References (54)

1. GA Homandberg C Wen F Hui 1998 Cartilage damaging activities of fibronectin fragments derived from cartilage and synovial fluid Osteoarthr Cartil 6 231 244 10.1053/joca.1998.0116 9876392 (Pubitemid 28341737)
2. QN Huynh S Wang E Tafolla SA Gansky S Kapila GC Armitage YL Kapila 2002 Specific fibronectin fragments as markers of periodontal disease status J Periodontol 73 1101 1110 10.1902/jop.2002.73.10.1101 12416766 (Pubitemid 35256260)
3. J Talonpoika J Heino H Larjava L Hakkinen K Paunio 1989 Gingival crevicular fluid fibronectin degradation in periodontal health and disease Scand J Dent Res 97 415 421 2694327
4. J Talonpoika K Paunio E Soderling 1993 Molecular forms and concentration of fibronectin and fibrin in human gingival crevicular fluid before and after periodontal treatment Scand J Dent Res 101 375 381 8290880
5. DL Xie R Meyers GA Homandberg 1992 Fibronectin fragments in osteoarthritic synovial fluid J Rheumatol 19 1448 1452 1433014
6. GA Homandberg R Meyers JM Williams 1993 Intraarticular injection of fibronectin fragments causes severe depletion of cartilage proteoglycans in vivo J Rheumatol 20 1378 1382 8230023
7. GA Homandberg R Meyers DL Xie 1992 Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture J Biol Chem 267 3597 3604 1740411
8. YL Kapila S Kapila PW Johnson 1996 Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells Matrix Biol 15 251 261 10.1016/S0945-053X(96)90116-X 8892225 (Pubitemid 26331684)
9. YL Kapila H Lancero PW Johnson 1998 The response of periodontal ligament cells to fibronectin J Periodontol 69 1008 1019 9776029
10. YL Kapila J Niu PW Johnson 1997 The high affinity heparin-binding domain and the V region of fibronectin mediate invasion of human oral squamous cell carcinoma cells in vitro J Biol Chem 272 18932 18938 10.1074/jbc.272.30.18932 9228073 (Pubitemid 27318246)
11. YL Kapila S Wang P Dazin E Tafolla MJ Mass 2002 The heparin-binding domain and V region of fibronectin regulate apoptosis by suppression of p53 and c-myc in human primary cells J Biol Chem 277 8482 8491 10.1074/jbc.M108932200 11751853 (Pubitemid 34968310)
12. YL Kapila S Wang PW Johnson 1999 Mutations in the heparin binding domain of fibronectin in cooperation with the V region induce decreases in pp125(FAK) levels plus proteoglycan-mediated apoptosis via caspases J Biol Chem 274 30906 30913 10.1074/jbc.274.43.30906 10521484 (Pubitemid 29503928)
13. E Tafolla S Wang B Wong J Leong YL Kapila 2005 JNK1 and JNK2 oppositely regulate p53 in signaling linked to apoptosis triggered by an altered fibronectin matrix: JNK links FAK and p53 J Biol Chem 280 19992 19999 10.1074/jbc.M500331200 15778501 (Pubitemid 41379528)
14. D Xie GA Homandberg 1993 Fibronectin fragments bind to and penetrate cartilage tissue resulting in proteinase expression and cartilage damage Biochim Biophys Acta 1182 189 196 8357850
15. R Dai A Iwama S Wang YL Kapila 2005 Disease-associated fibronectin matrix fragments trigger anoikis of human primary ligament cells: p53 and c-myc are suppressed Apoptosis 10 503 512 10.1007/s10495-005-1880-5 15909113 (Pubitemid 40896657)
16. CB Forsyth J Pulai RF Loeser 2002 Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes Arthritis Rheum 46 2368 2376 10.1002/art.10502 12355484
17. T Gemba J Valbracht S Alsalameh M Lotz 2002 Focal adhesion kinase and mitogen-activated protein kinases are involved in chondrocyte activation by the 29-kDa amino-terminal fibronectin fragment J Biol Chem 277 907 911 10.1074/jbc.M109690200 11677248 (Pubitemid 34968833)
18. GA Homandberg V Costa C Wen 2002 Fibronectin fragments active in chondrocytic chondrolysis can be chemically cross-linked to the alpha5 integrin receptor subunit Osteoarthr Cartil 10 938 949 10.1053/joca.2002.0854 12464554 (Pubitemid 35439419)
19. T Yasuda T Kakinuma SM Julovi M Yoshida T Hiramitsu M Akiyoshi T Nakamura 2004 COOH-terminal heparin-binding fibronectin fragment induces nitric oxide production in rheumatoid cartilage through CD44 Rheumatology 43 1116 1120 10.1093/rheumatology/keh274 15213332 (Pubitemid 39232816)
20. CL Brooks W Gu 2006 p53 ubiquitination: Mdm2 and beyond Mol Cell 21 307 315 10.1016/j.molcel.2006.01.020 16455486 (Pubitemid 43163526)
21. B Vogelstein D Lane AJ Levine 2000 Surfing the p53 network Nature 408 307 310 10.1038/35042675 11099028
22. Y Yang CC Li AM Weissman 2004 Regulating the p53 system through ubiquitination Oncogene 23 2096 2106 10.1038/sj.onc.1207411 15021897 (Pubitemid 38496739)
23. D Michael M Oren 2003 The p53-Mdm2 module and the ubiquitin system Semin Cancer Biol 13 49 58 10.1016/S1044-579X(02)00099-8 12507556 (Pubitemid 36269180)
24. CM Pickart 2001 Mechanisms underlying ubiquitination Annu Rev Biochem 70 503 533 10.1146/annurev.biochem.70.1.503 11395416 (Pubitemid 32663902)
25. AM Weissman 2001 Themes and variations on ubiquitylation Nat Rev Mol Cell Biol 2 169 178 10.1038/35056563 11265246 (Pubitemid 33675741)
26. A Mani EP Gelmann 2005 The ubiquitin-proteasome pathway and its role in cancer J Clin Oncol 23 4776 4789 10.1200/JCO.2005.05.081 16034054 (Pubitemid 46224082)
27. Ghosh A, Joo NE, Chen TC, Kapila YL (2010) Proapoptotic fibronectin fragment induces the degradation of ubiquitinated p53 via proteasomes in periodontal ligament cells. J Periodontal Res. doi: 10.1111/j.1600-0765.2009. 01261.x
28. MW Frazier X He J Wang Z Gu JL Cleveland GP Zambetti 1998 Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain Mol Cell Biol 18 3735 3743 9632756
29. TJ McDonnell R Montes de Oca Luna S Cho LL Amelse A Chavez-Reyes G Lozano 1999 Loss of one but not two mdm2 null alleles alters the tumour spectrum in p53 null mice J Pathol 188 322 328 10.1002/(SICI)1096-9896(199907)188:3<322:: AID-PATH372>3.0.CO;2-F 10419603 (Pubitemid 29317778)
30. SJ Baker S Markowitz ER Fearon JK Willson B Vogelstein 1990 Suppression of human colorectal carcinoma cell growth by wild-type p53 Science 249 912 915 10.1126/science.2144057 2144057
31. J Chen X Wu J Lin AJ Levine 1996 mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein Mol Cell Biol 16 2445 2452 8628312
32. Z Zhang M Li H Wang S Agrawal R Zhang 2003 Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy Proc Natl Acad Sci USA 100 11636 11641 10.1073/pnas.1934692100 13130078 (Pubitemid 37205988)
33. S Akhtar R Kole RL Juliano 1991 Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera Life Sci 49 1793 1801 10.1016/0024-3205(91)90480-Y 1943483
34. C Klein LT Vassilev 2004 Targeting the p53-MDM2 interaction to treat cancer Br J Cancer 91 1415 1419 15452548
35. LT Vassilev BT Vu B Graves D Carvajal F Podlaski Z Filipovic N Kong U Kammlott C Lukacs C Klein N Fotouhi EA Liu 2004 In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 Science 303 844 848 10.1126/science.1092472 14704432 (Pubitemid 38174664)
36. SK Kumar E Hager C Pettit H Gurulingappa NE Davidson SR Khan 2003 Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents J Med Chem 46 2813 2815 10.1021/jm030213+ 12825923 (Pubitemid 36775907)
37. MH Kubbutat SN Jones KH Vousden 1997 Regulation of p53 stability by Mdm2 Nature 387 299 303 10.1038/387299a0 9153396 (Pubitemid 27220767)
38. R Honda H Tanaka H Yasuda 1997 Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 FEBS Lett 420 25 27 10.1016/S0014-5793(97)01480-4 9450543 (Pubitemid 28037193)
39. SJ Duncan S Gruschow DH Williams C McNicholas R Purewal M Hajek M Gerlitz S Martin SK Wrigley M Moore 2001 Isolation and structure elucidation of Chlorofusin, a novel p53-MDM2 antagonist from a Fusarium sp J Am Chem Soc 123 554 560 10.1021/ja002940p 11456567 (Pubitemid 32105997)
40. J Zhao M Wang J Chen A Luo X Wang M Wu D Yin Z Liu 2002 The initial evaluation of non-peptidic small-molecule HDM2 inhibitors based on p53-HDM2 complex structure Cancer Lett 183 69 77 10.1016/S0304-3835(02)00084-8 12049816 (Pubitemid 34607353)
41. D Dornan I Wertz H Shimizu D Arnott GD Frantz P Dowd K O'Rourke H Koeppen VM Dixit 2004 The ubiquitin ligase COP1 is a critical negative regulator of p53 Nature 429 86 92 10.1038/nature02514 15103385 (Pubitemid 38620556)
42. RP Leng Y Lin W Ma H Wu B Lemmers S Chung JM Parant G Lozano R Hakem S Benchimol 2003 Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation Cell 112 779 791 10.1016/S0092-8674(03)00193-4 12654245 (Pubitemid 36378882)
43. Y Haupt R Maya A Kazaz M Oren 1997 Mdm2 promotes the rapid degradation of p53 Nature 387 296 299 10.1038/387296a0 9153395 (Pubitemid 27220766)
44. G Asher P Tsvetkov C Kahana Y Shaul 2005 A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73 Genes Dev 19 316 321 10.1101/gad.319905 15687255 (Pubitemid 40189294)
45. SL Harris AJ Levine 2005 The p53 pathway: positive and negative feedback loops Oncogene 24 2899 2908 10.1038/sj.onc.1208615 15838523 (Pubitemid 40638098)
46. J Momand GP Zambetti DC Olson D George AJ Levine 1992 The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Cell 69 1237 1245 10.1016/0092-8674(92)90644-R 1535557
47. JD Oliner KW Kinzler PS Meltzer DL George B Vogelstein 1992 Amplification of a gene encoding a p53-associated protein in human sarcomas Nature 358 80 83 10.1038/358080a0 1614537
48. L Girnita A Girnita O Larsson 2003 Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor Proc Natl Acad Sci USA 100 8247 8252 10.1073/pnas.1431613100 12821780 (Pubitemid 36842530)
49. SH Kimura H Nojima 2002 Cyclin G1 associates with MDM2 and regulates accumulation and degradation of p53 protein Genes Cells 7 869 880 10.1046/j.1365-2443.2002.00564.x 12167164 (Pubitemid 34947089)
50. A Nag S Bagchi P Raychaudhuri 2004 Cul4A physically associates with MDM2 and participates in the proteolysis of p53 Cancer Res 64 8152 8155 10.1158/0008-5472.CAN-04-2598 15548678 (Pubitemid 39491749)
51. MS Song SJ Song SY Kim HJ Oh DS Lim 2008 The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex EMBO J 27 1863 1874 10.1038/emboj.2008.115 18566590
52. Y Zhu MV Poyurovsky Y Li L Biderman J Stahl X Jacq C Prives 2009 Ribosomal protein S7 is both a regulator and a substrate of MDM2 Mol Cell 35 316 326 10.1016/j.molcel.2009.07.014 19683495
53. D Chen N Kon M Li W Zhang J Qin W Gu 2005 ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor Cell 121 1071 1083 10.1016/j.cell.2005.03. 037 15989956 (Pubitemid 40884397)
54. G Asher J Lotem L Sachs C Kahana Y Shaul 2002 Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1 Proc Natl Acad Sci USA 99 13125 13130 10.1073/pnas.202480499 12232053